M. Pescaru

Evaluation of the Relapse Risk and Survival Rate in Patients with Hodgkin Lymphoma: A Monocentric Experience

I. Ionita, E. Borsi, O. Potre, 2021, Medicina.

The Impact of Complex Treatment, Doxorubicin C27H29NO11, Bleomycin C55H84N17O21S3, Vinblastine C46H58N4O9 and Dacarbazine C6H10N6O Correlated with Haematological Parameters on Hodgkin�s Lymphoma Survival Prognostic

S. Iurciuc, H. Ioniță, A. Bucur, 2020 .

The Effects of the Therapeutic Regimen Used in Hodgkin Lymphoma and the Correlation with Prognosis Factors

H. Ioniță, L. Rusu, A. Bucur, 2018, Revista de Chimie.